Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using <i>Schistosoma mansoni</i> in Uganda-Reference-Cited by-同舟云学术

Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda

Published:2022-07-04 Issue:1 Volume:33 Page:78-102
ISSN:1128-7462
Container-title:Global Bioethics
language:en
Short-container-title:Global Bioethics

Author:

Egesa Moses¹²³^ORCID,Ssali Agnes⁴,Tumwesige Edward⁴,Kizza Moses¹,Driciru Emmanuella¹,Luboga Fiona²,Roestenberg Meta⁴⁵,Seeley Janet⁴⁶^ORCID,Elliott Alison M.¹⁷

Affiliation:

1. Immunomodulation and Vaccines Programme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda

2. Uganda Virus Research Institute, Entebbe, Uganda

3. Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK

4. Social Aspects of Health Across the Life-Course Programme, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda

5. Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands

6. Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK

7. Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK

Funder

HIC-Vac

Wellcome Trust

DELTAS Africa Initiative

Medical Research Council

Publisher

Informa UK Limited

Subject

Health Policy,Philosophy,Health (social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/11287462.2022.2091503

Reference47 articles.

1. Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10–11, 2019

2. Who Decides: Me or We? Family Involvement in Medical Decision Making in Eastern and Western Countries

3. Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines

4. Ethical Criteria for Human Challenge Studies in Infectious Diseases: Table 1.

5. What risks should be permissible in controlled human infection model studies?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi;Wellcome Open Research;2023-06-12

2. Perceptions and acceptability of the controlled human malaria infection (CHMI) model in The Gambia: a qualitative study;Scientific Reports;2023-05-29

3. Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial;Immunotherapy Advances;2023-01-01

4. Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease;Frontiers in Immunology;2022-10-03